The 5-lipoxygenase (5-LOX) Inhibitor Zileuton Reduces Inflammation and Infarct Size with Improvement in Neurological Outcome Following Cerebral Ischemia

MLA

Costa Silva, Bruno, et al. “The 5-Lipoxygenase (5-LOX) Inhibitor Zileuton Reduces Inflammation and Infarct Size with Improvement in Neurological Outcome Following Cerebral Ischemia.” Current Neurovascular Research, vol. 12, no. 4, Nov. 2015, pp. 398–403. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs36796683&authtype=sso&custid=ns315887.

APA

Costa Silva, B., Silva de Miranda, A., Guimaraes Rodrigues, F., Leticia Malheiros Silveira, A., Henrique de Souza Resende, G., Flavio Dutra Moraes, M., Carlos Pinheiro de Oliveira, A., Martins Parreiras, P., da Silva Barcelos, L., Martins Teixeira, M., Simao Machado, F., Lucio Teixeira, A., & Alvarenga Rachid, M. (2015). The 5-lipoxygenase (5-LOX) Inhibitor Zileuton Reduces Inflammation and Infarct Size with Improvement in Neurological Outcome Following Cerebral Ischemia. Current Neurovascular Research, 12(4), 398–403.

Chicago

Costa Silva, Bruno, Aline Silva de Miranda, Flavia Guimaraes Rodrigues, Ana Leticia Malheiros Silveira, Gustavo Henrique de Souza Resende, Marcio Flavio Dutra Moraes, Antonio Carlos Pinheiro de Oliveira, et al. 2015. “The 5-Lipoxygenase (5-LOX) Inhibitor Zileuton Reduces Inflammation and Infarct Size with Improvement in Neurological Outcome Following Cerebral Ischemia.” Current Neurovascular Research 12 (4): 398–403. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs36796683&authtype=sso&custid=ns315887.